Cardiovascular risk factor profiles and kidney function stage in the US general population: The NHANES III study

被引:112
作者
Foley, RN
Wang, CC
Collins, AJ
机构
[1] US Renal Data Syst, Coordinating Ctr, Minneapolis, MN 55404 USA
[2] Univ Minnesota, Minneapolis, MN USA
关键词
D O I
10.4065/80.10.1270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To determine the prevalence of cardiovascular risk factors in the general population based on kidney function. SUBJECTS AND METHODS: We retrospectively analyzed data from the Third National Health and Nutrition Examination Survey of noninstitutionalized US adults, which was conducted from 1988 to 1994. Data were gathered on 9 cardiovascular risk factors (smoking; obesity; hypertension; high total cholesterol, C-reactive protein, glycosylated hemoglobin, and homocysteine levels; low hemoglobin level; and high urinary album In-to-creatinine ratio) and estimated glomerular filtration rate (GFR). RESULTS: For the 15,837 subjects, the estimated GFR was at least 90 mL/min per 1.73 m(2) (normal) in 65.4%, 60 to 89.9 mL/ min per 1.73 m(2) (stage 2 kidney function) in 27.9%, 30 to 59.9 mL/min per 1.73 m(2) (stage 3 kidney function) in 6.2%, and less than 30 mL/min per 1.73 m(2) (stages 4 and 5 kidney function) in 0.5%. The number of cardiovascular risk factors Increased with stage of kidney dysfunction. Of subjects with a normal GFR, 30.4% had no risk factors, 34.9% had 1 risk factor, and 34.7% had 2 or more risk factors. Of subjects with stage 2 kidney function, 24.8% had no risk factors, 30.3% had 1 risk factor, and 44.9% had 2 or more risk factors. Of subjects with stage 3 kidney function, 1.4% had no risk factors, 14.9% had 1 risk factor, and 83.6% had 2 or more risk factors. All subjects with stages 4 and 5 kidney function had 2 or more risk factors. After covariate adjustment, odds ratios for having an estimated GFR lower than 60 mL/min per 1.73 m(2) were 1, 3.7 (95% confidence interval, 1.2-11.3), and 10.4 (95% confidence interval, 3.9-27.8) times greater in subjects with 0, 1, and 2 or more cardiovascular risk factors, respectively (P <=.001). CONCLUSION: Persons with chronic kidney disease are much more likely to need multiple cardiovascular risk factor interventions than those without chronic kidney disease.
引用
收藏
页码:1270 / 1277
页数:8
相关论文
共 42 条
[21]   Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial [J].
Mann, JFE ;
Gerstein, HC ;
Pogue, J ;
Bosch, J ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :629-636
[22]  
Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745
[23]  
*NCEP EXP PAN, 2002, NIH PUBL
[24]  
*NIH NAT HEART LUN, 2004, NIH PUBL
[25]   Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition [J].
Remuzzi, G ;
Ruggenenti, P ;
Perico, N .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (08) :604-615
[26]   Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. [J].
Ridker, PM ;
Rifai, N ;
Rose, L ;
Buring, JE ;
Cook, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1557-1565
[27]   PLASMA AMINO-ACID ABNORMALITIES IN CHRONIC RENAL-FAILURE [J].
ROBINS, AJ ;
BOOTH, EM ;
MILEWCZYK, BK ;
MALLICK, NP .
CLINICA CHIMICA ACTA, 1972, 42 (01) :215-+
[28]  
Samak MJ, 2002, CLIN NEPHROL, V57, P327
[29]   Cardiovascular disease and chronic renal disease: A new paradigm [J].
Sarnak, MJ ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :S117-S131
[30]   Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study [J].
Sarnak, MJ ;
Tighiouart, H ;
Manjunath, G ;
MacLeod, B ;
Griffith, J ;
Salem, D ;
Levey, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (01) :27-33